In Leukemia: REL overexpression and sustained NF-κB signaling associated with 2p gain induce resistance to BTK inhibitors in Chronic Lymphocytic Leukemia

REL overexpression and sustained NF-κB signaling associated with 2p gain induce resistance to BTK inhibitors in Chronic Lymphocytic Leukemia

Léa Dehgane, Eliane Mallet, Constance Brasseur, Daphné Krzisch, Wail Zeitouni, Casilda Hitier, Marianne Ayoub, Kenza Dubois, Claudia Pérez Carretero, Damien Roos-Weil, Sylvain Choquet, Karim Maloum, Clotilde Bravetti, Marine Armand, Delphine Garnier, Jesús-María Hernández-Rivas, Santos A Susin, Florence Nguyen-Khac, Elise Chapiro

Leukemia. 2025 Dec 9

Pubmed

In Leukemia: REL overexpression and sustained NF-κB signaling associated with 2p gain induce resistance to BTK inhibitors in Chronic Lymphocytic Leukemia

Published by GenoSplice on December 10, 2025December 10, 2025

In Cell Death Dis.: Regulation of NTRK2 alternative splicing by PRPF40B controls neural differentiation and synaptic plasticity

In J Cell Sci: Intestinal fibroblast heterogeneity: unifying RNA-seq studies and introducing consensus-driven nomenclature.

In Am J Hum Genet.: Heterozygous pathogenic variants in the splicing factor SF1 lead to a large spectrum of neurodevelopmental disorders.

In Leukemia: REL overexpression and sustained NF-κB signaling associated with 2p gain induce resistance to BTK inhibitors in Chronic Lymphocytic Leukemia

Published by GenoSplice on December 10, 2025December 10, 2025

Related Posts

In Cell Death Dis.: Regulation of NTRK2 alternative splicing by PRPF40B controls neural differentiation and synaptic plasticity

In J Cell Sci: Intestinal fibroblast heterogeneity: unifying RNA-seq studies and introducing consensus-driven nomenclature.

In Am J Hum Genet.: Heterozygous pathogenic variants in the splicing factor SF1 lead to a large spectrum of neurodevelopmental disorders.